Erotex-TH Tablet is a combination medication containing Etoricoxib 60mg and Thiocolchicoside 4mg, formulated for the management of musculoskeletal pain and inflammation associated with conditions such as osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and acute musculoskeletal spasms. Etoricoxib, a selective cyclooxygenase-2 (COX-2) inhibitor, provides effective analgesic and anti-inflammatory effects by reducing the synthesis of prostaglandins involved in pain and inflammation pathways, thereby minimizing gastrointestinal side effects commonly seen with non-selective NSAIDs. Thiocolchicoside is a muscle relaxant with antispasmodic properties that acts centrally to alleviate muscle stiffness and spasms, enhancing patient mobility and comfort. The combination of these two agents offers synergistic relief by addressing both inflammation and muscle spasm components of musculoskeletal disorders. Erotex-TH is typically prescribed for short-term use under medical supervision, with dosage adjustments based on clinical response and patient tolerance. Contraindications include hypersensitivity to either component, active peptic ulcer, severe hepatic or renal impairment, and certain cardiovascular conditions. Caution is advised in patients with a history of cardiovascular disease, gastrointestinal bleeding, or during pregnancy and lactation. Patients should adhere to prescribed dosages and consult healthcare providers if adverse reactions occur.